{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:45:42Z","timestamp":1791233142983,"version":"4.1.0"},"reference-count":170,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Cancer progression and therapeutic response remain highly variable across tumor types and are not fully explained by tumor-intrinsic alterations alone. The human microbiome has emerged as a systems-level regulator of cancer biology, integrating signals across immune, metabolic, neural, and endocrine axes. Microbial dysbiosis is associated with sustained inflammatory activation, genomic instability, and epigenetic reprogramming, linking microbial composition with tumor development. Microbiome-derived metabolites, including short-chain fatty acids (SCFAs), bile acids, and tryptophan derivatives, act as intermediates connecting microbial activity with host signaling networks that regulate immune cell function, metabolic pathways, neuroimmune communication, and hormonal balance. Convergence occurs through shared intracellular pathways, including NF-\u03baB, STAT3, and WNT\/\u03b2-catenin, shaping tumor initiation, progression, and therapeutic response. Microbiome-associated profiles have been proposed as diagnostic, prognostic, and predictive biomarkers, although clinical implementation remains limited by methodological variability, cohort heterogeneity, and lack of causal validation. The review integrates current evidence within a unified systems-level framework, defines mechanistic links between microbial functional outputs and host signaling pathways, and discusses microbiome-targeted strategies with relevance for precision oncology.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1887873","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T05:39:43Z","timestamp":1785130783000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["The microbiome as a systems-level regulator of immune, metabolic, neural, and endocrine signaling in cancer"],"prefix":"10.3389","volume":"17","author":[{"given":"Jhommara","family":"Bautista","sequence":"first","affiliation":[{"name":"Cancer Research Group (CRG), Faculty of Medicine, Universidad de Las Am\u00e9ricas","place":["Quito, Ecuador"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s","family":"L\u00f3pez-Cort\u00e9s","sequence":"additional","affiliation":[{"name":"Cancer Research Group (CRG), Faculty of Medicine, Universidad de Las Am\u00e9ricas","place":["Quito, Ecuador"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.medj.2025.100773","article-title":"Microbiota-derived metabolites: Key modulators of cancer immunotherapies","volume":"6","author":"Perl","year":"2025","journal-title":"Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1002\/imt2.70070","article-title":"The microbiome in cancer","volume":"4","author":"Lin","year":"2025","journal-title":"iMeta"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-025-01326-2","article-title":"The gut microbiota in cancer immunity and immunotherapy","volume":"22","author":"Xie","year":"2025","journal-title":"Cell Mol Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"100948","DOI":"10.1016\/j.lanmic.2024.07.011","article-title":"State of the art and the future of microbiome-based biomarkers: a multidisciplinary Delphi consensus","volume":"6","author":"Rodriguez","year":"2025","journal-title":"Lancet Microbe"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s44368-026-00019-w","article-title":"Engineering microbial metabolites to modulate tumor immunity and advance cancer immunotherapy","volume":"3","author":"Chigozie","year":"2026","journal-title":"Discov Immun"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2018.03.015","article-title":"The influence of the gut microbiome on cancer, immunity, and cancer immunotherapy","volume":"33","author":"Gopalakrishnan","year":"2018","journal-title":"Cancer Cell"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2025.1677481","article-title":"Deciphering organotropism reveals therapeutic targets in metastasis","volume":"13","author":"Bautista","year":"2025","journal-title":"Front Cell Dev Biol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.ccell.2025.03.013","article-title":"Diet-microbiome interactions in cancer","volume":"43","author":"Abdeen","year":"2025","journal-title":"Cancer Cell"},{"key":"B10","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.maturitas.2017.06.025","article-title":"Estrogen-gut microbiome axis: Physiological and clinical implications","volume":"103","author":"Baker","year":"2017","journal-title":"Maturitas"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e70504","DOI":"10.1002\/jmv.70504","article-title":"Unraveling the gut\u2010brain\u2010immune interplay in herpes simplex virus\u2010associated neurodegeneration","volume":"97","author":"Bautista","year":"2025","journal-title":"J Med Virol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2025.105708","article-title":"The metabolic dialogue between intratumoural microbes and cancer: implications for immunotherapy","volume":"115","author":"Situ","year":"2025","journal-title":"EBioMedicine"},{"key":"B13","doi-asserted-by":"publisher","first-page":"eabc4552","DOI":"10.1126\/science.abc4552","article-title":"The microbiome and human cancer","volume":"371","author":"Sepich-Poore","year":"2021","journal-title":"Science"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1152\/physrev.00018.2018","article-title":"The microbiota-gut-brain axis","volume":"99","author":"Cryan","year":"2019","journal-title":"Physiol Rev"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e01492\u201317","DOI":"10.1128\/mBio.01492-17","article-title":"Dysbiosis and its discontents","volume":"8","author":"Hooks","year":"2017","journal-title":"MBio"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-05989-7","article-title":"Profiling the human intestinal environment under physiological conditions","volume":"617","author":"Shalon","year":"2023","journal-title":"Nature"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2024.1475159","article-title":"The oral-gut microbiota relationship in healthy humans: identifying shared bacteria between environments and age groups","volume":"15","author":"Costa","year":"2024","journal-title":"Front Microbiol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1126\/science.aad3369","article-title":"Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity","volume":"352","author":"Zhernakova","year":"2016","journal-title":"Science"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2026.1801100","article-title":"The hallmarks of host-microbiome decoupling","volume":"17","author":"Bautista","year":"2026","journal-title":"Front Microbiol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2026.117556","article-title":"Microbial metabolites at the front line: Orchestrating gastrointestinal and systemic barrier immunity across the lifespan","volume":"45","author":"Koren","year":"2026","journal-title":"Cell Rep"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1169624","article-title":"Short-chain fatty acids, secondary bile acids and indoles: gut microbial metabolites with effects on enteroendocrine cell function and their potential as therapies for metabolic disease","volume":"14","author":"Masse","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B22","doi-asserted-by":"publisher","first-page":"15356","DOI":"10.1038\/s41598-025-98973-2","article-title":"Integrating metagenomics and metabolomics to study the gut microbiome and host relationships in sports across different energy systems","volume":"15","author":"Aya","year":"2025","journal-title":"Sci Rep"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.999001","article-title":"Human gut microbiota in health and disease: Unveiling the relationship","volume":"13","author":"Afzaal","year":"2022","journal-title":"Front Microbiol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.80810","article-title":"The bidirectional relationship between the gut microbiome and mental health: A comprehensive review","volume":"17","author":"Rathore","year":"2025","journal-title":"Cureus"},{"key":"B25","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/s41392-024-01946-6","article-title":"A systematic framework for understanding the microbiome in human health and disease: from basic principles to clinical translation","volume":"9","author":"Ma","year":"2024","journal-title":"Signal Transduct Tgt Ther"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1238-8","article-title":"The integrative human microbiome project","volume":"569","year":"2019","journal-title":"Nature"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2025.1701101","article-title":"Analyzing the gut liver axis: a dual role of the microbiome in the genesis, progression, and treatment of liver cell carcinoma","volume":"16","author":"Li","year":"2025","journal-title":"Front Microbiol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1126\/science.aay9189","article-title":"The human tumor microbiome is composed of tumor type-specific intracellular bacteria","volume":"368","author":"Nejman","year":"2020","journal-title":"Science"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2026.103036","article-title":"Gut microbiota-derived metabolites as immune modulators in aging and age-related chronic inflammatory diseases","volume":"116","author":"Chen","year":"2026","journal-title":"Ageing Res Rev"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2024.148923","article-title":"Population-specific differences in the human microbiome: Factors defining the diversity","volume":"933","author":"Govender","year":"2025","journal-title":"Gene"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2025.1672780","article-title":"Microbial beginnings: determinants and disruptions of the neonatal microbiome","volume":"16","author":"Bautista","year":"2025","journal-title":"Front Microbiol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s42523-023-00266-4","article-title":"Microbial community changes correlate with impaired host fitness of Aurelia aurita after environmental challenge","volume":"5","author":"Pinnow","year":"2023","journal-title":"Anim Microbiome"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.20517\/mrr.2024.78","article-title":"Early-life gut microbiome development and its potential long-term impact on health outcomes","volume":"4","author":"Borrego-Ruiz","year":"2025","journal-title":"MRR"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3390\/genes17010116","article-title":"Composition and function of gut microbiome: from basic omics to precision medicine","volume":"17","author":"Ma","year":"2026","journal-title":"Genes"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.hnm.2026.200364","article-title":"The interplay between gut microbiota metabolites and host body: Implications in health and disease","volume":"44","author":"Islam","year":"2026","journal-title":"Hum Nutr Metab"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.tifs.2026.105818","article-title":"Gut microbiota-derived metabolites as systemic messengers: mechanisms of gut-organ communication and translational opportunities","volume":"174","author":"Feng","year":"2026","journal-title":"Trends Food Sci Technol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2023.1197759","article-title":"Short chain fatty acids: the messengers from down below","volume":"17","author":"Mansuy-Aubert","year":"2023","journal-title":"Front Neurosci"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2025.1689597","article-title":"Regulatory mechanisms of the gut microbiota-short chain fatty acids signaling axis in slow transit constipation and progress in multi-target interventions","volume":"16","author":"Liu","year":"2025","journal-title":"Front Microbiol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.00368-25","article-title":"Gut microbiota-derived short-chain fatty acids (SCFAs): immunomodulatory effects and therapeutic potential in infections","author":"Yu","year":"2026","journal-title":"Clin Microbiol Rev"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2026.2665890","article-title":"The gut microbiome-bile acid-FXR interplay: a pivotal axis in metabolic and gastrointestinal diseases","volume":"18","author":"Shou","year":"2026","journal-title":"Gut Microbes"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2025.118182","article-title":"The bile acid-gut microbiota axis: A central hub for physiological regulation and a novel therapeutic target for metabolic diseases","volume":"188","author":"Zhao","year":"2025","journal-title":"BioMed Pharmacother"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2025.1696213","article-title":"Bile acid signaling mediates gut microbiota regulation of host lipid metabolism","volume":"16","author":"Liu","year":"2025","journal-title":"Front Microbiol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2023.1209613","article-title":"Modulation of immunity by tryptophan microbial metabolites","volume":"10","author":"Li","year":"2023","journal-title":"Front Nutr"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.942027","article-title":"Potential roles of gut microbial tryptophan metabolites in the complex pathogenesis of acne vulgaris","volume":"13","author":"Huang","year":"2022","journal-title":"Front Microbiol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70168","article-title":"Gut microbiota dysbiosis: pathogenesis, diseases, prevention, and therapy","volume":"6","author":"Shen","year":"2025","journal-title":"MedComm"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2026.1789194","article-title":"Gut microbiota dysbiosis-induced chronic inflammation as a driver of atherosclerosis: cellular crosstalk and host-microbe interactions","volume":"16","author":"Song","year":"2026","journal-title":"Front Cell Infect Microbiol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/s41392-025-02264-1","article-title":"Pattern recognition receptors: function, regulation and therapeutic potential","volume":"10","author":"Chen","year":"2025","journal-title":"Signal Transduct Tgt Ther"},{"key":"B48","doi-asserted-by":"publisher","first-page":"635","DOI":"10.3390\/biology15080635","article-title":"From microbial ecology to functional components in microbe-host interactions","volume":"15","author":"Wang","year":"2026","journal-title":"Biol (Basel)"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.115358","article-title":"De-coding the complex role of microbial metabolites in cancer","volume":"44","author":"P\u00e9rez Escriva","year":"2025","journal-title":"Cell Rep"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.221","article-title":"Human microbiomes in cancer development and therapy","volume":"4","author":"Xia","year":"2023","journal-title":"MedComm"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2025.1699893","article-title":"Gut microbiota and colorectal cancer: mechanistic insights, diagnostic advances, and microbiome-based therapeutic strategies","volume":"16","author":"Bai","year":"2025","journal-title":"Front Microbiol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2026.1857151","article-title":"Programming the tumor microenvironment through microbiome-driven mechanisms","volume":"16","author":"Bautista","year":"2026","journal-title":"Front Cell Infect Microbiol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.15992","article-title":"Invasive Fusobacterium nucleatum activates beta-catenin signaling in colorectal cancer via a TLR4\/P-PAK1 cascade","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1681824","article-title":"Microbiome influence in gastric cancer progression and therapeutic strategies","volume":"12","author":"Bautista","year":"2025","journal-title":"Front Med (Lausanne)"},{"key":"B55","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s13073-024-01344-1","article-title":"Colorectal cancer microbiome programs DNA methylation of host cells by affecting methyl donor metabolism","volume":"16","author":"Liu","year":"2024","journal-title":"Genome Med"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-025-01354-y","article-title":"Molecular mechanisms and regulation of inflammasome activation and signaling: sensing of pathogens and damage molecular patterns","volume":"22","author":"Dubey","year":"2025","journal-title":"Cell Mol Immunol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s12943-025-02403-w","article-title":"The tumor microbiome in cancer progression: mechanisms and therapeutic potential","volume":"24","author":"Zhang","year":"2025","journal-title":"Mol Cancer"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-025-02335-3","article-title":"Microbiota in cancer: current understandings and future perspectives","volume":"11","author":"Yao","year":"2026","journal-title":"Signal Transduct Tgt Ther"},{"key":"B59","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s44466-026-00040-6","article-title":"Toll-like receptors in innate immunity and inflammation: from fundamental biology to clinic insights","volume":"2","author":"Qian","year":"2026","journal-title":"Immun Inflammation"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2021.2022407","article-title":"Epigenetic regulation by gut microbiota","volume":"14","author":"Woo","year":"2022","journal-title":"Gut Microbes"},{"key":"B61","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3892\/ijmm.2025.5687","article-title":"Microbial short chain fatty acids: effective histone deacetylase inhibitors in immune regulation (Review)","volume":"57","author":"Wang","year":"2026","journal-title":"Int J Mol Med"},{"key":"B62","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1186\/s12967-024-05709-3","article-title":"Influence of the gut microbiota on immune cell interactions and cancer treatment","volume":"22","author":"Liu","year":"2024","journal-title":"J Transl Med"},{"key":"B63","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s40168-020-00847-4","article-title":"Bacteria pathogens drive host colonic epithelial cell promoter hypermethylation of tumor suppressor genes in colorectal cancer","volume":"8","author":"Xia","year":"2020","journal-title":"Microbiome"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202207366","article-title":"A review of gut microbiota-derived metabolites in tumor progression and cancer therapy","volume":"10","author":"Yang","year":"2023","journal-title":"Adv Sci (Weinh)"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2026.1737582","article-title":"Decoding the microbial blueprint of pancreatic cancer","volume":"13","author":"Bautista","year":"2026","journal-title":"Front Med (Lausanne)"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.417","article-title":"Microbiota in cancer: molecular mechanisms and therapeutic interventions","volume":"4","author":"Chen","year":"2023","journal-title":"MedComm"},{"key":"B67","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41522-025-00883-8","article-title":"Gut microbiome-driven colorectal cancer via immune, metabolic, neural, and endocrine axes reprogramming","volume":"12","author":"Bautista","year":"2026","journal-title":"NPJ Biofilms Microbiomes"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2026.1844436","article-title":"Microbiome and cancer: mechanistic insights, diagnostic potential, and therapeutic strategies","volume":"14","author":"Kumar","year":"2026","journal-title":"Front Cell Dev Biol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13045-024-01541-w","article-title":"Critical role of the gut microbiota in immune responses and cancer immunotherapy","volume":"17","author":"Li","year":"2024","journal-title":"J Hematol Oncol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s12672-025-04367-1","article-title":"The gut microbiome in colorectal cancer: mechanisms of carcinogenesis and emerging microbiota-targeted therapies","volume":"17","author":"Li","year":"2026","journal-title":"Discov Oncol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1016\/j.nutres.2024.05.007","article-title":"Current understanding of free fatty acids and their receptors in colorectal cancer treatment","volume":"127","author":"Binienda","year":"2024","journal-title":"Nutr Res"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1429436","article-title":"Microbiota activation and regulation of adaptive immunity","volume":"15","author":"Heidari","year":"2024","journal-title":"Front Immunol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2023-330291","article-title":"Roseburia intestinalis generated butyrate boosts anti-PD-1 efficacy in colorectal cancer by activating cytotoxic CD8+ T cells","volume":"72","author":"Kang","year":"2023","journal-title":"Gut"},{"key":"B74","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1016\/j.chom.2024.10.006","article-title":"Longitudinal analysis of the gut microbiota during anti-PD-1 therapy reveals stable microbial features of response in melanoma patients","volume":"32","author":"Macandog","year":"2024","journal-title":"Cell Host Microbe"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2026.2652476","article-title":"Modulating the gut microbiota to enhance immune checkpoint inhibitor efficacy in colorectal cancer: mechanisms, therapeutic strategies, and clinical perspectives","volume":"18","author":"Chen","year":"2026","journal-title":"Gut Microbes"},{"key":"B76","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12943-025-02566-6","article-title":"Intratumoral microbiome: the double-edged sword in remodeling cancer immunotherapy","volume":"25","author":"Yan","year":"2026","journal-title":"Mol Cancer"},{"key":"B77","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41392-023-01693-0","article-title":"Intratumoural microbiota: a new frontier in cancer development and therapy","volume":"9","author":"Cao","year":"2024","journal-title":"Signal Transduct Tgt Ther"},{"key":"B78","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41522-025-00786-8","article-title":"Gut microbiota shapes cancer immunotherapy responses","volume":"11","author":"Lei","year":"2025","journal-title":"NPJ Biofilms Microbiomes"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2025.1675065","article-title":"Immunomodulatory role of gut microbial metabolites: mechanistic insights and therapeutic frontiers","volume":"16","author":"Zeng","year":"2025","journal-title":"Front Microbiol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"e184321","DOI":"10.1172\/JCI184321","article-title":"The gut microbiome and cancer response to immune checkpoint inhibitors","volume":"135","author":"Gazzaniga","year":"2025","journal-title":"J Clin Invest"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1654792","article-title":"Microbial signatures in metastatic cancer","volume":"12","author":"Bautista","year":"2025","journal-title":"Front Med (Lausanne)"},{"key":"B82","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/s41591-024-02823-z","article-title":"A gut microbial signature for combination immune checkpoint blockade across cancer types","volume":"30","author":"Gunjur","year":"2024","journal-title":"Nat Med"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2025.102573","article-title":"Gut microbiome and obesity care: bridging dietary, surgical, and pharmacological interventions","volume":"7","author":"Masi","year":"2026","journal-title":"Cell Rep Med"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e35336","article-title":"Shaping the future of gastrointestinal cancers through metabolic interactions with host gut microbiota","volume":"10","author":"Xie","year":"2024","journal-title":"Heliyon"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-07754-w","article-title":"Gut microbiota carcinogen metabolism causes distal tissue tumours","volume":"632","author":"Roje","year":"2024","journal-title":"Nature"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1735873","article-title":"The metabolism-immune axis in colorectal cancer: remodeling the tumor microenvironment through metabolite signaling","volume":"16","author":"Hu","year":"2025","journal-title":"Front Immunol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-024-01012-x","article-title":"Gut microbiota-derived metabolites tune host homeostasis fate","volume":"46","author":"Kim","year":"2024","journal-title":"Semin Immunopathol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1713614","article-title":"Microbiota-host metabolism reprogramming in colorectal cancer: from pathogenesis to precision therapies","volume":"15","author":"Guo","year":"2025","journal-title":"Front Oncol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.cmet.2025.12.012","article-title":"Microbial metabolite FAD mobilizes adipocyte lipid remodeling to enhance cancer immunotherapy efficacy","volume":"38","author":"Tong","year":"2026","journal-title":"Cell Metab"},{"key":"B90","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.chom.2025.12.003","article-title":"Microbiota utilization of intestinal amino acids modulates cancer progression and anticancer immunity","volume":"34","author":"Qiao","year":"2026","journal-title":"Cell Host Microbe"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.115234","article-title":"Emerging insights into the impact of systemic metabolic changes on tumor-immune interactions","volume":"44","author":"Cote","year":"2025","journal-title":"Cell Rep"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2025.08.005","article-title":"Host and microbiome lipid metabolism in colorectal cancer development and therapy","volume":"11","author":"Medina Evora","year":"2025","journal-title":"Trends Cancer"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1111\/obr.70075","article-title":"Obesity as a systems-level driver of cancer: mechanisms and nutritional reprogramming","author":"Munteanu","year":"2025","journal-title":"Obes Rev"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1038\/s44324-025-00066-1","article-title":"Mechanisms and implications of the gut microbial modulation of intestinal metabolic processes","volume":"3","author":"Jyoti","year":"2025","journal-title":"NPJ Metab Health Dis"},{"key":"B95","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41392-025-02141-x","article-title":"Energy metabolism in health and diseases","volume":"10","author":"Liu","year":"2025","journal-title":"Signal Transduct Tgt Ther"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1093\/noajnl\/vdaf267","article-title":"From the gut to the brain: the involvement of the gut microbiota in the development and progression of glioblastoma","volume":"8","author":"Toumazi","year":"2026","journal-title":"Neuro-Oncol Adv"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2024.08.008","article-title":"Exploiting the gut microbiome for brain tumour treatment","volume":"31","author":"Keane","year":"2025","journal-title":"Trends Mol Med"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.217492","article-title":"Emerging neuroimmune mechanisms in cancer neuroscience","volume":"612","author":"Huang","year":"2025","journal-title":"Cancer Lett"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.34133\/research.0885","article-title":"Gut-brain-microbiome axis in the regulation of cancer immune escape and immunotherapy in tumors","volume":"8","author":"Xu","year":"2025","journal-title":"Res (Wash D C)"},{"key":"B100","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/s41392-025-02241-8","article-title":"Neuro-immune crosstalk in cancer: mechanisms and therapeutic implications","volume":"10","author":"Pu","year":"2025","journal-title":"Signal Transduct Tgt Ther"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-023-00949-8","article-title":"The cancer-immune dialogue in the context of stress","volume":"24","author":"Ma","year":"2024","journal-title":"Nat Rev Immunol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"270","DOI":"10.3390\/biom15020270","article-title":"Modulation of the neuro-cancer connection by metabolites of gut microbiota","volume":"15","author":"Mafe","year":"2025","journal-title":"Biomolecules"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-020-05739-9","article-title":"Microbiome-gut-brain axis in cancer treatment-related psychoneurological toxicities and symptoms: a systematic review","volume":"29","author":"Song","year":"2021","journal-title":"Supp Care Cancer"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1126\/science.1236361","article-title":"Autonomic nerve development contributes to prostate cancer progression","volume":"341","author":"Magnon","year":"2013","journal-title":"Science"},{"key":"B105","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s10571-026-01680-3","article-title":"The gut-brain-immune axis in glioma: emerging mechanisms and therapeutic opportunities","volume":"46","author":"Feng","year":"2026","journal-title":"Cell Mol Neurobiol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-025-10028-8","article-title":"Tumour-brain crosstalk restrains cancer immunity via a sensory-sympathetic axis","volume":"650","author":"Wei","year":"2026","journal-title":"Nature"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noaf024","article-title":"Intestinal Bacteroides drives glioma progression by regulating CD8+ T cell tumor infiltration","volume":"27","author":"Chatterjee","year":"2025","journal-title":"Neuro Oncol"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.62347\/OKKH6279","article-title":"Decoding the metastatic nexus: how chronic stress reprograms neuroendocrine-metabolic-microbiome circuits to fuel tumor metastasis","volume":"15","author":"Wang","year":"2025","journal-title":"Am J Cancer Res"},{"key":"B109","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1186\/s12964-025-02266-0","article-title":"The immunosuppressive effect of glucocorticoids in human primary T cells is mainly mediated via a rapid inhibition of the IL-2\/IL-2R signaling axis","volume":"23","author":"Albarracin Melo","year":"2025","journal-title":"Cell Commun Signal"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1016\/j.maturitas.2026.108830","article-title":"Impact of long-term medication on estrobolome-associated \u03b2-glucuronidase and sulfatase activities: Implications for estrogen homeostasis in postmenopausal women","volume":"206","author":"Mart\u00ednez-Nortes","year":"2026","journal-title":"Maturitas"},{"key":"B111","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41523-025-00810-2","article-title":"Longitudinal changes in gut microbiota composition during endocrine therapy in hormone receptor-positive breast cancer patients","volume":"11","author":"Tsai","year":"2025","journal-title":"NPJ Breast Cancer"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2026.1827694","article-title":"Host\u2013microbiome interactions in breast cancer progression and treatment response","volume":"13","author":"Bautista","year":"2026","journal-title":"Front Med (Lausanne)"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2023.2185035","article-title":"The role of the sex hormone-gut microbiome axis in tumor immunotherapy","volume":"15","author":"Wang","year":"2023","journal-title":"Gut Microbes"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2025.2599525","article-title":"Gut dysbiosis impacts estrogen levels in APP\/PS1 transgenic female mice","volume":"17","author":"Romero-Flores","year":"2025","journal-title":"Gut Microbes"},{"key":"B115","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.3390\/nu18071052","article-title":"Diet, the gut microbiome, and estrogen physiology: A review in menopausal health and interventions","volume":"18","author":"Lim","year":"2026","journal-title":"Nutrients"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1562332","article-title":"Gut microbiota has the potential to improve health of menopausal women by regulating estrogen","volume":"16","author":"Wang","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B117","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1002\/ijc.35427","article-title":"The estrobolome: Estrogen-metabolizing pathways of the gut microbiome and their relation to breast cancer","volume":"157","author":"Larnder","year":"2025","journal-title":"Int J Cancer"},{"key":"B118","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12905-025-04195-z","article-title":"Could the estrobolome have a role in endometriosis pathogenesis and infertility? A systematic review","volume":"26","author":"Saponara","year":"2025","journal-title":"BMC Womens Health"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1016\/j.coemr.2025.100571","article-title":"Sex hormones\u2013gut microbiome axis: An update of what is known so far","volume":"38","author":"Zommiti","year":"2025","journal-title":"Curr Opin Endocr Metab Res"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.5306\/wjco.v16.i9.108819","article-title":"Unraveling the links between estrogen and gut microbiota in sex-hormone driven cancers","volume":"16","author":"Tahri","year":"2025","journal-title":"World J Clin Oncol"},{"key":"B121","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12929-025-01208-9","article-title":"Microbiome modulation of tumorigenesis and immune responses","volume":"33","author":"Chen","year":"2026","journal-title":"J BioMed Sci"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1002\/ctd2.263","article-title":"Host\u2013microbiota interaction during cancer progression from bulk to single\u2010cell level","volume":"4","author":"Ma","year":"2024","journal-title":"Clin Trans Discov"},{"key":"B123","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s12672-026-04659-0","article-title":"Nervous and immune system crosstalk shapes cancer progression and treatment response","volume":"17","author":"Tardah","year":"2026","journal-title":"Discov Oncol"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2026.1776983","article-title":"Biohacking the human gut microbiome for precision health and therapeutic innovation","volume":"17","author":"Bautista","year":"2026","journal-title":"Front Microbiol"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2025.107816","article-title":"The gut-brain axis in the context of colorectal cancer","volume":"217","author":"Wu","year":"2025","journal-title":"Pharmacol Res"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-025-01212-6","article-title":"Gut dysbiosis in oncology: a risk factor for immunoresistance","volume":"36","author":"Almonte","year":"2026","journal-title":"Cell Res"},{"key":"B127","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/s41392-024-01765-9","article-title":"Harnessing innate immune pathways for therapeutic advancement in cancer","volume":"9","author":"Hu","year":"2024","journal-title":"Signal Transduct Tgt Ther"},{"key":"B128","doi-asserted-by":"publisher","first-page":"10609","DOI":"10.1038\/s41467-024-54565-8","article-title":"Integrative multi-omics analysis uncovers tumor-immune-gut axis influencing immunotherapy outcomes in ovarian cancer","volume":"15","author":"Rosario","year":"2024","journal-title":"Nat Commun"},{"key":"B129","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/s41698-024-00647-1","article-title":"Multi-omics machine learning to study host-microbiome interactions in early-onset colorectal cancer","volume":"8","author":"Jayakrishnan","year":"2024","journal-title":"NPJ Precis Oncol"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1734792","article-title":"Critical role of reproductive tract microbiota and derived metabolites in inflammation, tumor immunity, and tumorigenesis of gynecological cancers: a narrative review","volume":"17","author":"Chen","year":"2026","journal-title":"Front Immunol"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1093\/procel\/pwad052","article-title":"Emerging clinical relevance of microbiome in cancer: promising biomarkers and therapeutic targets","volume":"15","author":"Dai","year":"2024","journal-title":"Protein Cell"},{"key":"B132","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41522-025-00708-8","article-title":"Oral microbiome-derived biomarkers for non-invasive diagnosis of head and neck squamous cell carcinoma","volume":"11","author":"Zhi","year":"2025","journal-title":"NPJ Biofilms Microbiomes"},{"key":"B133","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/s41467-025-67047-2","article-title":"Tissue-resident microbiota impacts colorectal cancer progression and prognosis","volume":"17","author":"Shi","year":"2025","journal-title":"Nat Commun"},{"key":"B134","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/s41392-023-01406-7","article-title":"Role of the gut microbiota in anticancer therapy: from molecular mechanisms to clinical applications","volume":"8","author":"Zhao","year":"2023","journal-title":"Signal Transduct Tgt Ther"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2025.04.025","article-title":"Pharmacomicrobiomics: the role of the gut microbiome in immunomodulation and cancer therapy","volume":"169","author":"Bolte","year":"2025","journal-title":"Gastroenterology"},{"key":"B136","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41522-025-00678-x","article-title":"Gut microbiota as a new target for anticancer therapy: from mechanism to means of regulation","volume":"11","author":"Sun","year":"2025","journal-title":"NPJ Biofilms Microbiomes"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1038\/s44321-024-00185-0","article-title":"Gut microbiota interact with breast cancer therapeutics to modulate efficacy","volume":"17","author":"Arnone","year":"2025","journal-title":"EMBO Mol Med"},{"key":"B138","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s11912-024-01622-6","article-title":"Role of the microbiome and diet for response to cancer checkpoint immunotherapy: A narrative review of clinical trials","volume":"27","author":"Gamrath","year":"2025","journal-title":"Curr Oncol Rep"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-05728-y","article-title":"Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer","volume":"615","author":"Tintelnot","year":"2023","journal-title":"Nature"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2023.188990","article-title":"Modulating the gut microbiota by probiotics, prebiotics, postbiotics, and fecal microbiota transplantation: An emerging trend in cancer patient care","volume":"1878","author":"Ciernikova","year":"2023","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202502118R","article-title":"Microbial therapeutics in cancer: translating probiotics, prebiotics, synbiotics, and postbiotics from mechanistic insights to clinical applications: A topical review","volume":"39","author":"Tegegne","year":"2025","journal-title":"FASEB J"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02453-x","article-title":"Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial","volume":"29","author":"Routy","year":"2023","journal-title":"Nat Med"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2025.103025","article-title":"Fecal microbiota transplantation to enhance cancer treatment outcomes across different cancer types: A systematic literature review","volume":"140","author":"Wekking","year":"2025","journal-title":"Cancer Treat Rev"},{"key":"B144","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1186\/s12967-025-07407-0","article-title":"Advances in capsule-based fecal microbiota transplantation: clinical applications and innovations","volume":"23","author":"Yu","year":"2025","journal-title":"J Transl Med"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2025.2551882","article-title":"Effect of fecal microbiota transplantation on gut microbiota functional profile in recipients of allogeneic hematopoietic cell transplantation","volume":"17","author":"Ebadi","year":"2025","journal-title":"Gut Microbes"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-025-04186-5","article-title":"Fecal microbiota transplantation plus immunotherapy in non-small cell lung cancer and melanoma: the phase 2 FMT-LUMINate trial","volume":"32","author":"Duttagupta","year":"2026","journal-title":"Nat Med"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1007\/s44340-025-00031-0","article-title":"The mechanisms and therapeutic potential of the microbiome-immune interface in cancer","volume":"2","author":"Christina","year":"2025","journal-title":"Discov Bio\/Technol"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-08033-4","article-title":"Probiotic neoantigen delivery vectors for precision cancer immunotherapy","volume":"635","author":"Redenti","year":"2024","journal-title":"Nature"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-22-2626","article-title":"Live biotherapeutic products as cancer treatments","volume":"83","author":"Brevi","year":"2023","journal-title":"Cancer Res"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1016\/j.tim.2024.08.011","article-title":"Bioinformatics challenges for profiling the microbiome in cancer: pitfalls and opportunities","volume":"32","author":"Bokulich","year":"2024","journal-title":"Trends Microbiol"},{"key":"B151","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s13059-020-02037-9","article-title":"The promise and challenge of cancer microbiome research","volume":"21","author":"Manzoor","year":"2020","journal-title":"Genome Biol"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-025-02035-2","article-title":"Guidelines for preventing and reporting contamination in low-biomass microbiome studies","volume":"10","author":"Fierer","year":"2025","journal-title":"Nat Microbiol"},{"key":"B153","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/s41698-024-00617-7","article-title":"A review of machine learning methods for cancer characterization from microbiome data","volume":"8","author":"Teixeira","year":"2024","journal-title":"NPJ Precis Oncol"},{"key":"B154","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1093\/infdis\/jiae378","article-title":"Planning and analyzing a low-biomass microbiome study: a data analysis perspective","volume":"233","author":"Austin","year":"2026","journal-title":"J Infect Dis"},{"key":"B155","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1038\/s41467-024-46888-3","article-title":"Multi-omic integration of microbiome data for identifying disease-associated modules","volume":"15","author":"Muller","year":"2024","journal-title":"Nat Commun"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-24-3629","article-title":"Challenges and opportunities in analyzing cancer-associated microbiomes","volume":"85","author":"Chia","year":"2025","journal-title":"Cancer Res"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2025.1626799","article-title":"Shotgun metagenomics reveals antibiotic resistome dynamics and metabolic specialization in fungal-dominated microbiomes","volume":"16","author":"Zhao","year":"2025","journal-title":"Front Microbiol"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2026.1842279","article-title":"Host\u2013microbiome interactions in leukemia: mechanisms, treatment response, and clinical implications","volume":"16","author":"Bautista","year":"2026","journal-title":"Front Cell Infect Microbiol"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1038\/s41592-025-02807-y","article-title":"The new microbiome on the block: challenges and opportunities of using human tumor sequencing data to study microbes","volume":"22","author":"Li","year":"2025","journal-title":"Nat Methods"},{"key":"B160","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1186\/s13059-024-03401-9","article-title":"Assessing and mitigating batch effects in large-scale omics studies","volume":"25","author":"Yu","year":"2024","journal-title":"Genome Biol"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-024-02974-w","article-title":"Robustness of cancer microbiome signals over a broad range of methodological variation","volume":"43","author":"Sepich-Poore","year":"2024","journal-title":"Oncogene"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-02963-2","article-title":"Microbiome confounders and quantitative profiling challenge predicted microbial targets in colorectal cancer development","volume":"30","author":"Tito","year":"2024","journal-title":"Nat Med"},{"key":"B163","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/1040841X.2026.2629269","article-title":"Reprogramming human health through the microbiome and precision medicine","author":"Bautista","year":"2026","journal-title":"Crit Rev Microbiol"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2026.1766052","article-title":"Integrating microbiome insights into cervical cancer","volume":"13","author":"Bautista","year":"2026","journal-title":"Front Med (Lausanne)"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-025-03693-9","article-title":"Pooled analysis of 3,741 stool metagenomes from 18 cohorts for cross-stage and strain-level reproducible microbial biomarkers of colorectal cancer","volume":"31","author":"Piccinno","year":"2025","journal-title":"Nat Med"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1675677","article-title":"Microbial metabolites and their influence on the tumor microenvironment","volume":"16","author":"Duan","year":"2025","journal-title":"Front Immunol"},{"key":"B167","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13045-021-01103-4","article-title":"Spatial architecture of the immune microenvironment orchestrates tumor immunity and therapeutic response","volume":"14","author":"Fu","year":"2021","journal-title":"J Hematol Oncol"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.3389\/fragi.2026.1794192","article-title":"The microbiome-gerogene axis: a new frontier in precision geromedicine","volume":"7","author":"Bautista","year":"2026","journal-title":"Front Aging"},{"key":"B169","doi-asserted-by":"publisher","first-page":"467","DOI":"10.3390\/genes17040467","article-title":"Precision medicine through network language: integrating clinical insight and data expertise","volume":"17","author":"Palumbo","year":"2026","journal-title":"Genes"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1559480","article-title":"Microbiota as diagnostic biomarkers: advancing early cancer detection and personalized therapeutic approaches through microbiome profiling","volume":"16","author":"Eslami","year":"2025","journal-title":"Front Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1887873\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T05:39:45Z","timestamp":1785130785000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1887873\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,27]]},"references-count":170,"alternative-id":["10.3389\/fimmu.2026.1887873"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1887873","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,27]]},"article-number":"1887873"}}